Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database

AIMS/HYPOTHESIS: Using the Echantillon Généraliste de Bénéficiaires: random 1/97 permanent sample of the French national healthcare insurance system database (EGB), we investigated whether, as previously suspected, the risk of cancer in insulin glargine (A21Gly,B31Arg,B32Arg human insulin) users is...

Descripción completa

Detalles Bibliográficos
Autores principales: Blin, P., Lassalle, R., Dureau-Pournin, C., Ambrosino, B., Bernard, M. A., Abouelfath, A., Gin, H., Le Jeunne, C., Pariente, A., Droz, C., Moore, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268990/
https://www.ncbi.nlm.nih.gov/pubmed/22222504
http://dx.doi.org/10.1007/s00125-011-2429-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268990/
https://www.ncbi.nlm.nih.gov/pubmed/22222504
http://dx.doi.org/10.1007/s00125-011-2429-5

Ejemplares similares